MCW Pharmacy School Logo White Medical School
Bradley Stockard, PharmD, PhD

Bradley Stockard, PharmD, PhD

Assistant Professor


  • MCW Pharmacy School
    HRC H2714

Contact Information


BS, Biology, University of Missouri – Kansas City
PharmD, University of Missouri – Kansas City
PhD, Pharmaceutical Sciences, University of Florida
Fellowship, Clinical Pharmacology, Children’s Mercy Hospital, Kansas City


BLS Provider
Techniques in Modeling Human Cancer in Mice, Jackson Laboratory
Bloodborne Pathogen Training
Hazardous Waste Management


Bradley Stockard, PharmD, PhD joined the MCW School of Pharmacy on August 15, 2022. He received his PharmD from the University of Missouri – Kansas City School of Pharmacy and PhD in Pharmaceutical Sciences from the University of Florida. He is a graduate of the Clinical Pharmacology T32 Fellowship program which he completed at Children’s Mercy Hospital in Kansas City, MO. He served as Chief Fellow from 2021-2022. During his fellowship, he completed a research rotation with the Center for Drug Evaluation and Research department at the FDA. His research interests are in multi-omics association studies on variations in treatment outcomes for pediatric leukemias and neonatology. He has presented his research at American Society of Hematology and American Society of Clinical Pharmacology and Therapeutic Annual Conferences.

Research Interests

Clinical Implementation of Pharmacogenomics

  • Pharmacogenomics of Variable Response to Chemotherapy
  • Cancer Metabolism and Metabolomics
  • Multi-omics of Variable Drug Response in Neonatology


I believe that teachers should expect to engage students and motivate them to learn with enthusiasm. My hope is that students leave my class not just with knowledge but also with an understanding of why it is important for patient care. It is increasingly important to treat patients as individuals as they respond to pharmacotherapy. My goal is to communicate that importance to students so that they can recognize these differences and adjust treatments proactively.

Bradley Stockard, PharmD, PhD